These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

597 related articles for article (PubMed ID: 25348731)

  • 21. Adaptive Individualized high-dose preoperAtive (AIDA) chemoradiation in high-risk rectal cancer: a phase II trial.
    Guido A; Cuicchi D; Castellucci P; Cellini F; Di Fabio F; Llimpe FLR; Strigari L; Buwenge M; Cilla S; Deodato F; Macchia G; Galietta E; Golfieri R; Ardizzoni A; Zagari RM; Fanti S; Poggioli G; Fuccio L; Morganti AG
    Eur J Nucl Med Mol Imaging; 2023 Jan; 50(2):572-580. PubMed ID: 36127416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor SUVmax Normalized to Liver Uptake on (18)F-FDG PET/CT Predicts the Pathologic Complete Response After Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer.
    Park J; Chang KJ; Seo YS; Byun BH; Choi JH; Moon H; Lim I; Kim BI; Choi CW; Lim SM
    Nucl Med Mol Imaging; 2014 Dec; 48(4):295-302. PubMed ID: 26396634
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Predicting Response to Neoadjuvant Chemoradiotherapy in Esophageal Cancer with Textural Features Derived from Pretreatment
    Beukinga RJ; Hulshoff JB; van Dijk LV; Muijs CT; Burgerhof JGM; Kats-Ugurlu G; Slart RHJA; Slump CH; Mul VEM; Plukker JTM
    J Nucl Med; 2017 May; 58(5):723-729. PubMed ID: 27738011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prediction of neoadjuvant radiation chemotherapy response and survival using pretreatment [(18)F]FDG PET/CT scans in locally advanced rectal cancer.
    Bang JI; Ha S; Kang SB; Lee KW; Lee HS; Kim JS; Oh HK; Lee HY; Kim SE
    Eur J Nucl Med Mol Imaging; 2016 Mar; 43(3):422-31. PubMed ID: 26338180
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of
    Rufini V; Collarino A; Calcagni ML; Meduri GM; Fuoco V; Pasciuto T; Testa AC; Ferrandina G; Gambacorta MA; Campitelli M; Gui B; Zannoni G; Manfredi R; Scambia G; Giordano A
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1228-1238. PubMed ID: 31414206
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The Predictive Value of Baseline Volumetric PET/CT Parameters on Treatment Response and Prognosis in Locally Advanced Rectal Cancer Treated with Neoadjuvant Chemoradiotherapy.
    Sakin A; Sahin S; Karyagar SS; Karyagar S; Atci M; Akboru MH; Cihan S
    J Gastrointest Cancer; 2022 Jun; 53(2):341-347. PubMed ID: 33651265
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [(18)F]FPRGD2 PET/CT imaging of integrin αvβ3 levels in patients with locally advanced rectal carcinoma.
    Withofs N; Martinive P; Vanderick J; Bletard N; Scagnol I; Mievis F; Giacomelli F; Coucke P; Delvenne P; Cataldo D; Gambhir SS; Hustinx R
    Eur J Nucl Med Mol Imaging; 2016 Apr; 43(4):654-62. PubMed ID: 26490751
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Is diffusion-weighted MRI superior to FDG-PET or FDG-PET/CT in evaluating and predicting pathological response to preoperative neoadjuvant therapy in patients with rectal cancer?
    Li YL; Wu LM; Chen XX; Delproposto Z; Hu JN; Xu JR
    J Dig Dis; 2014 Oct; 15(10):525-37. PubMed ID: 25060294
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Response of locally advanced rectal cancer (LARC) to radiochemotherapy: DW-MRI and multiparametric PET/CT in correlation with histopathology.
    Cerny M; Dunet V; Rebecchini C; Hahnloser D; Prior J; Sempoux C; Schmidt S
    Nuklearmedizin; 2019 Feb; 58(1):28-38. PubMed ID: 30769371
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of volumetric and textural analysis in predicting the treatment response in patients with locally advanced rectal cancer.
    Karahan Şen NP; Aksu A; Kaya GÇ
    Ann Nucl Med; 2020 Dec; 34(12):960-967. PubMed ID: 32951129
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Metabolic Tumor Volume on 18F-FDG PET/CT Improves Preoperative Identification of High-Risk Endometrial Carcinoma Patients.
    Husby JA; Reitan BC; Biermann M; Trovik J; Bjørge L; Magnussen IJ; Salvesen ØO; Salvesen HB; Haldorsen IS
    J Nucl Med; 2015 Aug; 56(8):1191-8. PubMed ID: 26045311
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reduction of
    Wu F; Zhang X; Yang C; Wang K; Xiao L; Zhou C; Zhao X; Wang G
    Front Oncol; 2022; 12():1037783. PubMed ID: 36620536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Areas of high 18F-FDG uptake on preradiotherapy PET/CT identify preferential sites of local relapse after chemoradiotherapy for non-small cell lung cancer.
    Calais J; Thureau S; Dubray B; Modzelewski R; Thiberville L; Gardin I; Vera P
    J Nucl Med; 2015 Feb; 56(2):196-203. PubMed ID: 25572091
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prediction of Recurrence and Mortality of Locally Advanced Esophageal Cancer Patients Using Pretreatment F-18 FDG PET/CT Parameters: Intratumoral Heterogeneity, SUV, and Volumetric Parameters.
    Chang S; Kim SJ
    Cancer Biother Radiopharm; 2016 Feb; 31(1):1-6. PubMed ID: 26844846
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Positron emission tomography for predicting pathologic response after neoadjuvant chemoradiotherapy for locally advanced rectal cancer.
    Chennupati SK; Quon A; Kamaya A; Pai RK; La T; Krakow TE; Graves E; Koong AC; Chang DT
    Am J Clin Oncol; 2012 Aug; 35(4):334-9. PubMed ID: 21422989
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Standardized Index of Shape (DCE-MRI) and Standardized Uptake Value (PET/CT): Two quantitative approaches to discriminate chemo-radiotherapy locally advanced rectal cancer responders under a functional profile.
    Petrillo A; Fusco R; Petrillo M; Granata V; Delrio P; Bianco F; Pecori B; Botti G; Tatangelo F; Caracò C; Aloj L; Avallone A; Lastoria S
    Oncotarget; 2017 Jan; 8(5):8143-8153. PubMed ID: 28042958
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Accuracy of
    Valkema MJ; Noordman BJ; Wijnhoven BPL; Spaander MCW; Biermann K; Lagarde SM; Bennink RJ; Schreurs WMJ; Roef MJ; Hobbelink MGG; Janssen MJR; Graven LH; van Lanschot JJB; Valkema R
    J Nucl Med; 2019 Nov; 60(11):1553-1559. PubMed ID: 30877177
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential (18)F-FDG and (18)F-FLT Uptake on Serial PET/CT Imaging Before and During Definitive Chemoradiation for Non-Small Cell Lung Cancer.
    Everitt SJ; Ball DL; Hicks RJ; Callahan J; Plumridge N; Collins M; Herschtal A; Binns D; Kron T; Schneider M; MacManus M
    J Nucl Med; 2014 Jul; 55(7):1069-74. PubMed ID: 24833494
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Predictive value of (18)FDG PET-CT for tumour response in patients with locally advanced rectal cancer treated by preoperative chemoradiotherapy.
    Kim JW; Kim HC; Park JW; Park SC; Sohn DK; Choi HS; Kim DY; Chang HJ; Baek JY; Kim SY; Kim SK; Oh JH
    Int J Colorectal Dis; 2013 Sep; 28(9):1217-24. PubMed ID: 23404344
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prognostic value of posttreatment
    Lima GM; Matti A; Vara G; Dondi G; Naselli N; De Crescenzo EM; Morganti AG; Perrone AM; De Iaco P; Nanni C; Fanti S
    Eur J Nucl Med Mol Imaging; 2018 Nov; 45(12):2139-2146. PubMed ID: 30069578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 30.